How do you use Camzyos in a sentence? See 2 example sentences showing how this word appears in different contexts.
Camzyos in a sentence
Context around Camzyos
- Average sentence length in these examples: 31 words
- Position in the sentence: 0 start, 1 middle, 1 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Camzyos
- In this selection, "camzyos" usually appears in the middle of the sentence. The average example has 31 words, and this corpus slice is mostly made up of statements.
- Around the word, drug stand out and add context to how "camzyos" is used.
- Recognizable usage signals include cardiovascular drug camzyos is expected and sotyktu and camzyos. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "camzyos" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with camzyos
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
However, BMS’s new cardiovascular drug Camzyos is expected to bridge the gap from the expected decline in Eliquis sales. (20 words)
These are the company's aggressive M&A policy, which allowed it to acquire best-in-class drugs, an extremely high dividend yield exceeding 4.6%, high rates of Opdivo's label expansion, and continued extremely high demand for Sotyktu and Camzyos. (42 words)
These are the company's aggressive M&A policy, which allowed it to acquire best-in-class drugs, an extremely high dividend yield exceeding 4.6%, high rates of Opdivo's label expansion, and continued extremely high demand for Sotyktu and Camzyos. (42 words)
However, BMS’s new cardiovascular drug Camzyos is expected to bridge the gap from the expected decline in Eliquis sales. (20 words)
Example sentences (2)
These are the company's aggressive M&A policy, which allowed it to acquire best-in-class drugs, an extremely high dividend yield exceeding 4.6%, high rates of Opdivo's label expansion, and continued extremely high demand for Sotyktu and Camzyos.
However, BMS’s new cardiovascular drug Camzyos is expected to bridge the gap from the expected decline in Eliquis sales.